TrialDiabetes, obesity & metabolism2025

Ranibizumab with luseogliflozin in type 2 diabetes with diabetic macular oedema: A randomised clinical trial.

Ryoichi Ishibashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.